article thumbnail

Ten Action Items for Healthcare Portfolio Companies in 2024

JD Supra: Mergers

The investor-backed provider community may be feeling pressure and facing scrutiny from various angles in 2024, as federal and state agencies implement complex pre-closing review processes for healthcare transactions from an antitrust and oversight perspective. On the economic side,….

article thumbnail

Trending Enforcement Targeting Private Equity Healthcare Portfolios Provides Important Compliance Reminder

JD Supra: Mergers

Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Supporting the Health of your Healthcare Organization

JD Supra: Mergers

Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. Long-term capital gains tax rates will likely remain unchanged, or possibly drop. By: DLA Piper

article thumbnail

California Governor Vetoes Further Legislative Efforts to Restrict Healthcare Investments and Management Relationships

JD Supra: Mergers

By: DLA Piper

article thumbnail

Recent Ruling Shows Healthcare Private Equity Firms a Path Through the New Antitrust Era

JD Supra: Mergers

Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up" strategy of its anesthesia practice management portfolio company. The case, Federal Trade Commission v.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Avista Acquires EBI From Highridge Medical

JD Supra: Mergers

Avista Healthcare Partners has announced the acquisition of EBI. EBI, launched in 1979 and based in Parsippany, New Jersey, is a division of Highridge Medical that offers a portfolio of implantable and non-invasive bone growth stimulation solutions. By: McGuireWoods LLP

Medical 130
article thumbnail

Is Your Compliance House In Order? Tips for Ensuring Private Equity and Portfolio Company Compliance in the Wake of the Recent Request for Information

JD Supra: Mergers

The recent Request for Information by the Federal Trade Commission (FTC), Department of Justice (DOJ) and Department of Health and Human Services (HHS) seeking input on the effects of private equity (PE) investment in the healthcare sector underscores the importance of an effective compliance program.